Rhelixa is a biotechnology company that provides various advanced genomic and epigenomic research services.
Rhelixa's investors include Global Brain Corporation, Mitsubishi Corporation, Japan Finance Corporation, Daiwa Corporate Investment, Joyo Bank.
Rhelixa is headquartered in Tokyo, Japan.
Rhelixa is a biotechnology company that provides various advanced genomic and epigenomic research services.
Rhelixa is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rhelixa — Funding & Investors." VCBacked, August 22, 2024, https://www.vcbacked.co/company/rhelixa. Accessed October 29, 2026.
VCBacked. (2024). Rhelixa — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/rhelixa
{{cite web |title=Rhelixa — Funding & Investors |url=https://www.vcbacked.co/company/rhelixa |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated